Towards a versatile platform based on magnetic nanoparticles for in vivo applications

Magnetic nanoparticles have attracted wide attention because of their usefulness as contrast agents for magnetic resonance imaging (MRI) or colloidal mediators for cancer magnetic hyperthermia. This paper examines these in vivo applications through an understanding of the problems involved and the current and future possibilities for resolving them. A special emphasis is made on magnetic nanoparticle requirements from a physical viewpoint, the factors affecting their biodistribution and the solutions envisaged for enhancing their half-life in the blood compartment and targeting tumour cells. Then, our synthesis strategies are presented and focused on covalent platforms based on maghemite and dextran and capable to be tailorderivatized by surface molecular chemistry. The opportunity of taking advantage of temperature-dependence of magnetic properties of some complex oxides for controlling the in vivo temperature is also discussed.

[1]  A. Vekris,et al.  Synthesis, magnetic properties, surface modification and cytotoxicity evaluation of Y3Fe5−xAlxO12 (0⩽x⩽2) garnet submicron particles for biomedical applications , 2001 .

[2]  Peter Wust,et al.  Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. , 2004, Medical physics.

[3]  F. Veronese,et al.  Stabilization of substances in circulation. , 1998, Bioconjugate chemistry.

[4]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[5]  Sébastien Vasseur,et al.  Lanthanum manganese perovskite nanoparticles as possible in vivo mediators for magnetic hyperthermia , 2006 .

[6]  Paolo Colombo,et al.  Metallic colloid nanotechnology, applications in diagnosis and therapeutics. , 2005, Current pharmaceutical design.

[7]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[8]  P Wust,et al.  Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[9]  D. Jaillard,et al.  Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. , 2005, Bioconjugate chemistry.

[10]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[11]  C. W. Jung.  Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[12]  Elazer R. Edelman,et al.  Adv. Drug Delivery Rev. , 1997 .

[13]  F. Gilbert,et al.  Magnetic resonance imaging in oncology: an overview. , 1999, Journal of the Royal College of Surgeons of Edinburgh.

[14]  H. Nowak,et al.  Magnetism in Medicine , 2006 .

[15]  R. Costo,et al.  Progress in the preparation of magnetic nanoparticles for applications in biomedicine , 2003, Magnetic Nanoparticles in Biosensing and Medicine.

[16]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[17]  C. Breathnach.  Magnetism in medicine. , 1983, Irish medical journal.

[18]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[19]  Catherine C. Berry,et al.  Functionalisation of magnetic nanoparticles for applications in biomedicine , 2003 .

[20]  P. Moroz,et al.  Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  Peter Wust,et al.  Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro , 1999 .

[22]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.

[23]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[24]  Dhirendra Bahadur,et al.  Biomaterials and magnetism , 2003 .

[25]  Wolfgang Ebert,et al.  Tissue-specific MR contrast agents. , 2003, European journal of radiology.

[26]  Etienne Duguet,et al.  A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran , 2005 .

[27]  B. Bonnemain,et al.  Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. , 1998, Journal of drug targeting.

[28]  É. Duguet,et al.  Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .

[29]  Okuhata,et al.  Delivery of diagnostic agents for magnetic resonance imaging. , 1999, Advanced drug delivery reviews.